Jihye Bang

Dr. Jihye Bang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJihye Bang
Jihye Bang
MKMin-Soo Kim
Min-Soo Kim
WJWon Kyung Jeon
Won Kyung Jeon
Chronic cerebral hypoperfusion (CCH) causes cognitive impairment and neurogenic inflammation by reducing blood flow. We previously showed that Fructus mume (F. mume) improves cognitive impairment and inhibits neuroinflammation in a CCH rat model. One of the components of F. mume, Mumefural (MF), is known to improve blood flow and inhibit platelet aggregation. Whether MF affects cerebral and cognitive function remains unclear. We investigated the effects of MF on cognitive impairment and neurological function-related protein expression in the rat CCH model, established by bilateral common carotid arterial occlusion (BCCAo). Three weeks after BCCAo, MF (20, 40, or 80 mg/kg) was orally administrated once a day for 42 days. Using Morris water maze assessment, MF treatment significantly improved cognitive impairment. MF treatment also inhibited cholinergic system dysfunction, attenuated choline acetyltransferase-positive cholinergic neuron loss, and regulated cholinergic system-related protein expressions in the basal forebrain and hippocampus. MF also inhibited myelin basic protein degradation and increased the hippocampal expression of synaptic markers and cognition-related proteins. Moreover, MF reduced neuroinflammation, inhibited gliosis, and attenuated the activation of P2X7 receptor, TLR4/MyD88, NLRP3, and NF-κB. This study indicates that MF ameliorates cognitive impairment in BCCAo rats by enhancing neurological function and inhibiting neuroinflammation.

10 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJihye Bang
Jihye Bang
WJWon Kyung Jeon
Won Kyung Jeon
Mumefural (MF), a bioactive component of the processed fruit of Prunus mume Sieb. et Zucc, is known to inhibit platelet aggregation induced by agonists in vitro. In this study, we investigated the anti-thrombotic effects of MF using a rat model of FeCl3-induced arterial thrombosis. Sprague–Dawley rats were intraperitoneally injected with MF (0.1, 1, or 10 mg/kg) 30 min before 35% FeCl3 treatment to measure the time to occlusion using a laser Doppler flowmeter and to assess the weight of the blood vessels containing thrombus. MF treatment significantly improved blood flow by inhibiting occlusion and thrombus formation. MF also prevented collagen fiber damage in injured vessels and inhibited the expression of the platelet activation-related proteins P-selectin and E-selectin. Moreover, MF significantly reduced the increased inflammatory signal of nuclear factor (NF)-κB, toll-like receptor 4 (TLR4), tumor necrosis factor (TNF)-α, and interleukin (IL)-6 in blood vessels. After administration, MF was detected in the plasma samples of rats with a bioavailability of 36.95%. Therefore, we suggest that MF may improve blood flow as a candidate component in dietary supplements for improving blood flow and preventing blood circulation disorders.

31 December 2023 in Archives of Rheumatology
Verified
Journal Article
Open access
PDF file
JBJihye Bang
Jihye Bang
GKGyeonghwa Kim
Gyeonghwa Kim
JPJun Yong Park
Jun Yong Park
HJHye Ra Jung
Hye Ra Jung
SKSang-Hyon Kim
Sang-Hyon Kim
JKJi-Min Kim
Ji-Min Kim
Objectives: This study aimed to determine whether GCSB-5 has anti-inflammatory and antinociceptive effects in mice with collagen-induced arthritis (CIA), an animal model of rheumatoid arthritis (RA), and investigate the influence of GCSB-5 on the mitogen-activated protein kinase (MAPK) pathway. Materials and methods: The experimental animal study was designed to include five groups: CIA mice treated with GCSB-5 (300 mg/kg), GCSB-5 (600 mg/kg), celecoxib (60 mg/kg), or saline for four weeks, and nontreated control mice. The clinical severity of arthritis was scored. Nociceptive thresholds were measured by using a von Frey dynamic plantar analgesimeter. The MAPK pathway was evaluated in mouse synovium. The expression of channels associated with pain signaling was assessed by western blot and immunohistochemical staining. Results: GCSB-5 treatment diminished the severity of clinical arthritis and increased the nociceptive threshold in mice with CIA. Celecoxib, a positive control drug, also showed comparable changes. Clinical arthritis scores were inversely related to mechanical thresholds. GCSB-5 administration decreased the levels of anti-type II collagen antibody and inflammatory cytokines in the sera of mice with CIA. Furthermore, ERK, p38 MAPK, and JNK phosphorylation were downregulated and TRPV1 and ASIC3 expression were decreased in the synovium of GCSB-5-treated mice compared to salinetreated mice. Interleukin-6-induced TRPV1 and ASIC3 upregulation were also inhibited by GCSB-5 in human RA fibroblast-like synoviocytes in vitro. Conclusion: GCSB-5 decreased inflammatory arthritis and pain in a murine model of RA. The results present evidence that GCSB-5 may be beneficial for relieving pain as well as decreasing inflammation in autoimmune arthritis, such as RA.

1 January 2026 in Indoor Air
Verified
Journal Article
Open access
PDF file
JBJihye Bang
Jihye Bang
DHDoo Hee Han
Doo Hee Han
Kihong ParkKihong Park
Kihong Park
HHHee-Soo Han
Hee-Soo Han
HJHan Byul Jang
Han Byul Jang
YKYoung-Youl Kim
Young-Youl Kim
Particulate matter (PM), a key component of air pollution, is globally associated with adverse health effects, including premature mortality. Although the majority of the human lifespan is spent indoors, knowledge on the effects of indoor exposure to aerosol particles remains limited. Therefore, we aimed to investigate the effects of exposure to PM 2.5 (≤ 2.5 μ m) generated during indoor cooking on Alzheimer’s disease (AD). To investigate the signaling pathways activated by pork combustion PM 2.5 (PC‐PM 2.5 ), 2‐month‐old 5× FAD mice were exposed to whole‐body inhalation five times a week for 1 month. PC‐PM 2.5 ‐exposed mice were evaluated using the airway hyperresponsiveness test, novel object location recognition (NLR) task, and Y‐maze task, and glial cell localization was observed in the hippocampal brain regions. Additionally, cognition‐related markers (BDNF and CREB), amyloid beta (A β ) accumulation, pro‐inflammatory response, post‐synapse 95 (PSD95), and Wnt/GSK3 β signaling pathway expression were measured in hippocampal lysates to evaluate pathological changes. PC‐PM 2.5 treatment considerably increased A β accumulation and airway hyperresponsiveness and decreased cognitive function in 5× FAD mice. PC‐PM 2.5 treatment accelerated A β accumulation and pro‐inflammatory cytokine expression, as well as GFAP + localization, and reduced cognition‐related markers and synaptic plasticity in the hippocampus. Additionally, in the PC‐PM 2.5 ‐treated group, Wnt expression was lower than that in 5× FAD mice, GSK3 β phosphorylation increased, and nuclear translocation of β ‐catenin decreased. Therefore, this study confirmed that exposure to PC‐PM 2.5 , which is common in daily life, accelerates cognitive decline as a risk factor for AD and suggests that regulating the Wnt/GSK3 β / β ‐catenin pathway may be a potential prevention strategy. In summary, this study elucidates the changes and molecular signaling pathways activated by PM exposure and provides insights into the mechanistic links between air pollution and neurodegenerative diseases such as AD.